ArticleThe neuroradiology journal2019

Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.

Francesco Buemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.